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Androgen action via testicular peritubular myoid cells
is essential for male fertility
Michelle Welsh,* Philippa T. K. Saunders,* Nina Atanassova,† Richard M. Sharpe,*
and Lee B. Smith*,1
*Medical Research Council Human Reproductive Sciences Unit, Centre for Reproductive Biology,
The Queen’s Medical Research Institute, Edinburgh, UK; and the †Institute of Experimental
Morphology and Anthropology with Museum, Bulgarian Academy of Sciences, Sofia, Bulgaria
ABSTRACT Androgens are essential for normal sper-
matogenesis and male fertility, but how androgens exert
this effect remains uncertain. Androgen receptors (ARs)
are expressed in several testicular cell types, but continu-
ing uncertainty exists over which cell type mediates andro-
gen control of spermatogenesis. Androgen signaling via
Sertoli cells (SCs) is essential for complete spermatogen-
esis, but the role for androgen signaling via peritubular
myoid (PTM) cells is contentious. To address this contro-
versy, we generated PTM-specific AR-knockout (PTM-
ARKO) mice in which gross reproductive development
was normal, but all PTM-ARKO males were azoospermic
and infertile. Testis weight was reduced beyond puberty,
and in adulthood there was an 86% reduction in germ
cells, compared with wild-type littermates. These changes
were not explained by any deficits in testosterone, lutein-
izing hormone, or follicle-stimulating hormone concentra-
tions. SC function was impaired in PTM-ARKO males,
indicated by reduced seminiferous tubule fluid produc-
tion and reduced expression of some androgen-depen-
dent SC genes. Androgen action via PTM cells is there-
fore essential for normal testis function, spermatogenesis,
and fertility in males. This study also provides the first
direct evidence for the importance of androgen-driven
stromal-epithelial interactions underpinning the regula-
tion of spermatogenesis; PTM-ARKO mice will enable
identification of the new molecular pathways involved.—
Welsh, M., Saunders, P. T. K., Atanassova, N., Sharpe,
R. M., Smith, L. B. Androgen action via testicular peritu-
bular myoid cells is essential for male fertility. FASEB J.
23, 4218–4230 (2009). www.fasebj.org
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Testosterone is essential for normal male fertility,
controlling both the initiation and maintenance of sper-
matogenesis (1, 2). However, limited progress has been
made in understanding how these processes are effected.
This ignorance has hindered the development of new
male contraceptives and treatments for male infertility,
which is the most common cause of couple infertility (3).
Testosterone is produced in the testes by the Leydig
cells (LCs) and binds to the androgen receptor (AR) to
modulate gene transcription in target cells (4). AR is
expressed in several testicular cell types, but continuing
uncertainty exists over which of these cell types medi-
ates androgen control of spermatogenesis. Germ cells
(GCs) lacking AR mature normally (5); therefore,
testosterone is believed to regulate spermatogenesis via
AR expression in testicular somatic cells, namely the
Sertoli cells (SCs), the peritubular myoid (PTM) cells,
or LCs themselves. SCs have long been considered the
prime candidates because of their intimate contact with
the developing GCs (6). This theory has been investi-
gated directly by ablating AR in SCs (SCARKO mice)
using the Cre/lox system, and it was shown that these
mice are infertile because the GCs fail to complete
meiosis (7, 8). However, in other androgen-dependent
tissues, such as the prostate gland, AR signaling via the
stromal cells has a profound influence on organ devel-
opment and epithelial cell function (9, 10). If the same
stromal-epithelial interactions apply in the testis, we
would expect the stromal PTM cells to play a pivotal
role in mediating effects of androgens on epithelial SC
function and spermatogenesis.
PTM cells surround the seminiferous tubules and
express AR from fetal life through to adulthood, unlike
the SCs, which only become androgen responsive post-
natally (11). Despite many years of research, surpris-
ingly little is known about the role for PTM cells in male
fertility. It has been shown in vivo that loss of PTM cells
results in abnormal spermatogenesis (12), and 2 de-
cades ago it was postulated that PTM cells might
mediate androgenic control of spermatogenesis (13) as
they interact intimately with SCs, for example, in laying
down the basement membrane that surrounds the
seminiferous tubules (14, 15). Furthermore, in vitro
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evidence shows that androgens can stimulate PTM cells
to secrete factors that modulate SC function and thus
GC development (13, 16). Unfortunately, these PTM-
derived secretory factors remain unidentified (16, 17).
More recently, Cre/lox technology was used in mice to
delete AR from PTM cells, and although this resulted in
reduced sperm production, it did not result in male
infertility (18). This result initially suggested that an-
drogen action via PTM cells was not essential for
spermatogenesis. However, an independent study (19)
later reported that the SM22-Cre line used in these
experiments to ablate AR functioned poorly in the
testis, whereas, in contrast, Cre recombinase was highly
expressed in the testis in smMHC-Cre mice. This raises
the possibility that the mild phenotype reported by
Zhang et al. in their PTM cell AR knockout (KO) (18)
might not truly reflect the importance of androgen
action via PTM cells.
The aim of our studies, therefore, was to compare the
ability to ablate AR signaling via testicular PTM cells
using both of these Cre mouse lines to provide defini-
tive evidence for the role for AR signaling via PTM cells
in male fertility.
MATERIALS AND METHODS
Breeding of transgenic mice
Mice in which the AR has been selectively ablated from the
PTM cells were generated using Cre/loxP technology. PTM
cells are smooth muscle cells; therefore, to delete AR from
these cells, male mice heterozygous for Cre recombinase
under the control of a smooth muscle myosin heavy chain
(MH) (20) or a smooth muscle 22 (SM) as used by Zhang et
al. (18), on an identical strain background (21) promoter
were mated to female mice homozygous for a floxed AR (8).
The Cre-positive (ARflox-positive) male offspring from these
matings are termed MHAR KO (later termed PTM-ARKO)
and SMAR KO, respectively, whereas the Cre-negative, ARflox-
positive littermates were used as controls (termed WT).
Mouse nomenclature is summarized in Table 1. Cre-positive,
ARflox-negative mice were also generated by mating MH or SM
Cre-positive stud males to C57BL/6J females to confirm that
expression of Cre alone did not induce a phenotype. Sex and
genotype ratios were all identified at the expected Mendelian
ratios. Complete androgen receptor knockout (ARKO) mice
were generated as published previously (22). All mice were
bred under standard conditions of care and use under
licensed approval from the UK Home Office.
PCR genotyping of mice
Stud male MH or SM mice were identified by genotyping from
ear or tail DNA for the presence of Cre using standard PCR
(http://jaxmice.jax.org/pub-cgi/protocols/protocols.sh?objtype
protocol&protocol_id288). Females homozygous for ARflox
were identified using primers for AR exon 2 (7); these primers
revealed bands of 1142, 1072, and 612 bp, relating to mice with
a floxed, WT, or excised allele of the AR, respectively. All MHAR
and SMAR male offspring were genotyped for the presence of
Cre using the primers detailed above; all male offspring were
hemizygous for X-linked ARflox.
Evaluation of fertility
To investigate fertility, postnatal day (d)50 and 100 MHAR
KO and WT males were each housed with an adult C57BL/6J
female for 4 days. This process was repeated with 3 subse-
quent WT females per male. Female mice were monitored for
25 days for litters to be born.
Recovery of reproductive tissues
Male mice were culled at various postnatal ages (d12–140) by
inhalation of carbon dioxide and subsequent cervical dislo-
cation. Body weight and anogenital distance were measured,
and mice were examined for any gross abnormalities of the
reproductive system. Testes, seminal vesicles, and ventral
prostates were removed from the mice and weighed, whereas
epididymides and vas deferens were recovered but not
weighed. To collect fetal testes, dams were culled at embry-
onic day (e)17.5, and fetuses were recovered, decapitated,
and placed in ice-cold PBS (Sigma, Poole, UK). Testes were
collected from male fetuses and weighed. Tissues were either
snap-frozen for subsequent RNA analysis or fixed in Bouin’s
fixative for 6 h. Bouin’s-fixed tissues were processed and
embedded in paraffin wax, and 5-m sections were used for
histological analysis as reported previously (23). Sections of
testis and epididymis were stained with hematoxylin and eosin
using standard protocols and examined for histological ab-
normalities.
Determination of testicular cell composition
Standard stereological techniques involving point counting of
cell nuclei were used as described (8) to determine the
nuclear volume per testis of SCs, GCs, and the relative
volumes of interstitium, seminiferous epithelium, and semi-
niferous tubule lumen. In brief, cross sections of testes from
4 to 6 MHAR KO or WT mice at d12, 21, 50, and 100 were
examined using a Leitz 363 plan apo objective lens (63)
fitted to a Leitz Laborlux microscope and a 121-point eye-
piece graticule (Leica Microsystems, Wetzlar, Germany). For
each animal, 32–64 microscopic fields were counted, and
values for percent nuclear volume were converted to absolute
nuclear volumes per testis by reference to testis volume
(weight). SC and LC nuclear size and seminiferous tubule
diameter were determined using an Olympus Optical BH-2
microscope (Olympus Optical Co., Tokyo, Japan) fitted with
a Prior automatic stage (Prior Scientific Instruments, Cam-
bridge, UK) and Image-Pro Plus (version 4.5.1) with Stere-
ologer-Pro 5 plug-in software (Media Cybernetics, Bethesda,
MD, USA). Data were used to determine the relative contri-
bution of seminiferous epithelium and lumen to the testis
TABLE 1. Nomenclature of mouse strains
Cre line Target Knockout name
SM as used by Zhang et al. (18) Blood vessel smooth muscle SMAR KO
MH Peritubular myoid cells MHAR KO/PTM-ARKO
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volume, the average seminiferous tubule diameter, the nu-
clear volumes of and number of SCs and LCs per testis at
d100, and the nuclear volume per testis of each type of GC.
Immunohistochemical analysis
In addition to PCR genotyping, mice were examined by
immunohistochemistry for the presence of Cre and absence of
AR in PTM cells, identified by immunoexpression of smooth
muscle actin (SMA). AR expression in SCs and LCs was
confirmed by fluorescent costaining of AR with WT-1 or
3-hydroxysteroid dehydrogenase/5-4 isomerase
(3HSD), respectively. Single colorimetric immunohistochemis-
try was also performed for desmin, to demonstrate the smooth
muscle layer; laminin, to highlight the basement membrane; WT-1,
to demonstrate the location of SC nuclei; -tubulin isotype III
(Tubb3) expression in SCs; and luteinizing hormone (LH) recep-
tor expression in LCs.
Sections were deparaffinized, rehydrated, and antigen re-
trieved before blocking of nonspecific binding sites, as de-
tailed previously (23). Sections were incubated overnight at
4°C with the primary antibody diluted accordingly (Table 2).
Immunostaining was detected using the secondary antibody
and detection system specified in Table 2. Diaminobenzidine
immunostained slides were counterstained with hematoxylin,
dehydrated, and mounted with Pertex (Histolab, Gothen-
burg, Sweden), and images were captured using a Provis
microscope (Olympus) equipped with a Kodak DCS330 cam-
era (Eastman Kodak, Rochester, NY, USA). Fluorescent im-
munostained sections were mounted in Mowiol mounting
medium (Calbiochem, San Diego, CA, USA), and fluorescent
images were captured using a Zeiss LSM 510 Meta Axiovert
100M confocal microscope (Carl Zeiss Ltd., Welwyn, UK). To
ensure reproducibility of results, representative testes from
3 animals at each age were used, and sections from PTM-
ARKO and WT littermates were processed in parallel on the
same slide on 2 occasions. Appropriate negative controls
were included to ensure that any staining observed was
specific. The antibody for Cre recombinase results in GC
staining, even in mice genotyped as Cre-negative; this staining
was considered nonspecific. All other antibodies used showed
only minor nonspecific staining.
Hormone analysis
Immediately after culling, blood was collected from mice by
cardiac puncture. Sera were separated and stored at 	20°C
until assayed. Follicle-stimulating hormone (FSH), LH, and
testosterone were measured using previously published assays
(24, 25). Intratesticular testosterone concentrations were
measured as published previously (26). All samples from each
mouse were run in a single assay for each hormone, and the
within-assay coefficients of variation were all 
10%.
RNA extraction and reverse transcription
RNA was isolated from frozen testes from MHAR KO or WT
mice using the RNeasy Mini extraction kit with RNase-free
DNase on the column digestion kit (Qiagen, Crawley, UK)
according to the manufacturer’s instructions. For quantitative
RT-PCR, 5 ng of luciferase mRNA (Promega Corp., Madison,
WI) was added to each testis sample before RNA extraction as
an external standard (27). RNA was quantified on a Thermo
Scientific NanoDrop 1000 spectrophotometer (Thermo Sci-
entific, San Jose, CA, USA). Random hexamer primed cDNA
was prepared using the Applied Biosystems TaqMan reverse
transcription kit (Applied Biosystems, Foster City, CA, USA)
according to the manufacturer’s instructions.
Determination of deletion of AR exon 2
RT-PCR was performed using BioMix Red Taq polymerase
(Bioline, London, UK) on cDNA synthesized from testes from
PTM-ARKO mice and WT littermates using primers for AR
exons 1 and 3 (forward AAGCAGGTAGCTCTGGGACA; re-
verse CGTTTCTGCTGGCACATAGA); these primers re-
vealed bands of 765 and 613 bp, relating to mice with a WT
and or excised exon 2 allele of AR, respectively. A weak
central band was also identified; this was confirmed to be an
artifact by repeating the RT-PCR for AR exon 2 using gel-
purified combined AR exon 2 PCR products from ARKO and
WT mice as a template (i.e., no genomic DNA was included in
the reaction, yet the central band was present).
Quantitative analysis of gene expression
Quantitative PCR was performed for the genes listed in Table
3, using an ABI Prism 7500 Sequence Detection System
(Applied Biosystems) and the Roche Universal ProbeLibrary
(Roche, Welwyn, UK), according to the manufacturer’s in-
structions. Expression of each gene was related to luciferase,
an external positive control, and all genes were expressed per
testis.
TABLE 2. Immunohistochemistry antibody details
Antibody Antibody source Dilution Detection system
3HSD/AR
3HSD Santa Cruz Technology Inc. (Santa Cruz, CA, USA) 1:4000 Tyramide 488
AR Santa Cruz 1:50 Goat anti-rabbit Alexa 546
Cre/SMA
Cre Abcam (Cambridge, UK) 1:5000 Tyramide 488
SMA Sigma-Aldrich (St. Louis, MO, USA) 1:500 Goat anti-mouse Alexa 633
Cre/SMA/AR
Cre/SMA Abcam 1:5000 Tyramide 488
Cre Sigma 1:500 Goat anti-mouse Alexa 633
SMA Santa Cruz 1:1000 Tyramide 546
Desmin Dako (Cambridge, UK) 1:400 Goat anti-mouse biotinylated  DAB
Laminin Abcam 1:100 Goat anti-rabbit biotinylated  DAB
LH receptor Santa Cruz 1:200 Tyramide 488
Tubb3 Sigma 1:2000 Goat anti-mouse biotinylated  DAB
WT-1 Dako 1:1000 Goat anti-mouse biotinylated  DAB
DAB, diaminobenzidine.
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Statistical analysis
Data were analyzed using GraphPad Prism (version 5;
GraphPad Software Inc., San Diego, CA, USA) using a
1-tailed unpaired t test or a 1-way ANOVA, followed by
Bonferroni post hoc tests. Values are expressed as means 
se. Normality was confirmed using the Kolmogorov-
Smirnov normality test.
Figure 1. Characterization of Cre re-
combinase expression in adult PTM-
ARKO and SMAR testes. A) Approx-
imately 50% of male MHAR and
SMAR were Cre-positive (MHAR KO
and SMAR KO), identified by the
presence of a band at 100 bp. WT
littermates were negative for Cre but
were positive for the internal control
gene. B) Deletion of AR in the testes
was determined using RT-PCR span-
ning exon 2. Only the larger 765-bp
WT band was seen in MHAR and
SMAR WT testes, whereas the smaller
613-bp KO band was seen in ARKO
testes. Both bands were identified in
MHAR and SMAR KO testes, showing
deletion of AR in a proportion of
cells (central band is a PCR artifact).
C) Cre recombinase was expressed in
many PTM cells in testes from adult
MHAR KO (arrow) but not from
MHAR WT littermates (arrowhead)
or from KO or WT SMAR mice. How-
ever, smooth muscle cells around tes-
ticular blood vessels were positive for
Cre in MHAR and SMAR KO mice
(arrow). Not all PTM cells in MHAR
KO testes were Cre recombinase-pos-
itive (arrowhead). Scale bars  25
m. D) Immunohistochemical analy-
sis for AR (red), Cre recombinase
(green), and smooth muscle action
(SMA; blue) confirmed that AR was
deleted in a proportion of PTM cells
(arrow) in MHAR KO testes but not
in WT testes (arrowhead).
TABLE 3. TaqMan primer details
Gene Forward primer Reverse primer
ABP TTGTACCCAAAAGTCACTCAGG ATCTCTCCCTTGGGGCTTTA
Eppin GCACGTGCCAAGTCTTCAT CCTCTGTTCAGGTGAGACTGC
Rhox5 (Pem) AAATGAGCCAGTTGCTGAGG ATCTGCCTACCCCCAGGAT
Tubb3 GGCAACTATGTAGGGGACTCAG CCTGGGCACATACTTGTGAG
WT-1 (all isoforms) CACCAAAGGAGACACACAGG GGGAAAACTTTCGCTGACAA
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RESULTS
Generation and characterization of mice with deletion
of AR in PTM cells
No reproductive phenotype was identified at d100 in
Cre-positive, ARflox-negative male mice from both MH
and SM lines, showing that expression of Cre alone had
no effect (data not shown). All MHAR and SMAR males
were hemizygous for X-linked ARflox, whereas 50% of
these males also carried the Cre transgene (Fig. 1A,
KO); the ARflox-positive Cre-negative male littermates
were used as WT controls.
To confirm that Cre recombinase was functioning in
these mice, we assayed for the deletion of exon 2 of the
AR in testes from MHAR and SMAR males by RT-PCR.
MHAR and SMAR WT testes only expressed the full-
length (WT) band whereas ARKO testes only expressed
the smaller KO band, confirming that exon 2 of the AR
had been deleted from all cells (Fig. 1B). Testes from
MHAR and SMAR KOs expressed both the WT and the
KO band, as expected, demonstrating that AR had been
deleted only from a proportion of cells within the testis
(Fig. 1B). Note that the weak central band was con-
firmed to be a PCR artifact (data not shown).
Immunohistochemical analysis was therefore under-
taken to identify which cells in the testes expressed Cre
recombinase. MHAR WTs showed no specific testicular
Cre recombinase immunoexpression at d100, whereas
both the PTM cells and the smooth muscle cells around
the blood vessels stained positively for Cre recombinase
in MHAR KO mice (Fig. 1C). Variation was seen in the
proportion of PTM cells staining positively for Cre
recombinase both between and within different mice
(Fig. 1C). The average proportion of Cre recombinase-
positive PTM cells was 40% (ranging between 24 and
82%). SMAR WTs also showed no specific testicular Cre
recombinase immunoexpression at d100, whereas the
smooth muscle cells around the blood vessels immuno-
stained for Cre recombinase in SMAR KO mice (Fig.
1C). No Cre recombinase immunostaining was seen in
PTM cells in any SMAR Cre-positive KO mice (Fig. 1C).
Immunohistochemical analysis for AR, costained with
SMA and Cre recombinase (Fig. 1D), showed that, as
expected, AR and Cre recombinase were never coex-
pressed in the same cell (Fig. 1D). AR was detected in
all PTM cell nuclei in MHAR WT (Fig. 1D), SMAR WT
(data not shown), and SMAR KO (data not shown)
testes at d100. Conversely, AR was absent from many,
but not all, PTM cells in MHAR KO testes (Fig. 1D). AR
was also absent from the blood vessel smooth muscle
cells in both MHAR KO and SMAR KO testes (data not
shown).
As we have conclusively shown that the PTM cells do
not express Cre recombinase and continue to express
AR in Cre-positive SMAR mice, further analysis was only
undertaken in MHAR mice. From this point, MHAR
KO mice will be referred to as PTM-ARKO.
Onset of Cre recombinase expression in PTM-ARKO
testes
PTM-ARKO testes at e17.5–d100 were assayed for the
deletion of exon 2 of the AR by RT-PCR of cDNA, as
used in Fig. 1B. Testes from MHAR WT littermate mice
at all ages expressed only the full-length (WT) band,
whereas testes from PTM-ARKO mice at e17.5 ex-
pressed both the WT and the smaller KO band (Fig. 2).
Therefore, AR has been deleted from PTM cells around
the age at which AR is normally first expressed.
Characterization of the reproductive system in
PTM-ARKO mice
Body weight was not significantly different between
PTM-ARKO and WT males at any age (data not shown).
Male PTM-ARKO mice showed normal external sexual
development, anogenital distance, and penis length
(data not shown). In contrast to ARKO mice (8), the
reproductive tract formed normally in PTM-ARKO
males (Fig. 3A); however, seminal vesicle and ventral
prostate weights were reduced at d100, compared with
those in the WT littermates (data not shown). In
PTM-ARKOs, testes were normally descended in adults
but were obviously smaller than those in the WT
littermates (Fig. 3A and inset). Testis weight was signif-
icantly reduced in PTM-ARKO mice from d15 onward,
but not at d12 (Fig. 3A). Note that expression of Cre
alone, without ARflox expression, had no effect on testis
weight at d100 (Fig. 3A).
PTM-ARKO mice are infertile
WT males sired litters in 72% of matings (26 of 36),
whereas no PTM-ARKO males sired any litters (0 of 30).
Consistent with this result, only a few sperm were
observed in the epididymides from PTM-ARKOs at
d100, although cell debris was apparent in the epidid-
ymal lumens (Fig. 4).
Postnatal testis morphology and cell numbers
No dramatic testicular phenotype was observed in
PTM-ARKO males at d12 (Fig. 5A), but at d21, the
Figure 2. Deletion of AR in the testes was determined using
RT-PCR spanning exon 2. Only the larger 765-bp WT band
was seen in WT testes, whereas only the smaller 613-bp KO
band was seen in ARKO testes. Both bands were identified in
PTM-ARKO testes at e17.5, showing deletion of AR in a
proportion of testicular cells in fetal life.
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seminiferous epithelium appeared disorganized com-
pared with that of WT males, with cells often observed
abnormally in the middle of the tubules (Fig. 5A). This
disorganization remained apparent at d50 and 100
(Fig. 5A). At all ages, a layer of peritubular cells was
observed surrounding the seminiferous tubules in the
PTM-ARKO and WT testes (Fig. 5A). Stereological
quantification demonstrated a reduction in seminifer-
ous tubule lumen volume in PTM-ARKO testes at all
ages examined (Fig. 5B) and a reduction in seminifer-
ous tubule diameter at d50 and 100 (data not shown),
as was obvious on gross inspection (Fig. 5A).
The total volume of GCs was normal at d12 in
PTM-ARKOs but was significantly reduced at d21–100,
compared with that in WT littermates (Fig. 6); unlike in
SCARKO mice, this was due to a reduction in the
number of all types of GCs (Table 4). A progressive loss
of spermatogonia was observed in PTM-ARKO mice
with age, which reached significance at d100 (Table 4).
A significant reduction in spermatocyte number was
already apparent at d21 and persisted throughout
adulthood; this reduction was more dramatic than that
seen in adult SCARKO mice (Table 4). The number of
round spermatids was also significantly reduced in
PTM-ARKO testes at d21–100 (data not shown). This
was the most advanced stage of GC development in WT
testes at d21; however, the number of elongated sper-
matids (and thus the total number of spermatids) was
also reduced in adult PTM-ARKO testes (Table 4). In
addition, there was a reduction in the number of GCs
supported by each SC in the PTM-ARKO testis at
d21–100, as seen in SCARKO mice (Table 4).
PTM cell protein expression in PTM-ARKO testes
Smooth muscle protein expression was examined to
investigate the direct effect of PTM-ARKO on the PTM
cells. A reduction in desmin expression was noted in
PTM cells, whereas no change in desmin immunoexpres-
sion was observed in the smooth muscle cells surrounding
the blood vessels in PTM-ARKOs (Fig. 7A). This reduc-
tion was progressive with very little desmin immunoex-
pression in PTM cells in PTM-ARKO testes at d100 (Fig.
7A). SMA immunoexpression was slightly reduced
(data not shown). PTM cells contribute to the seminif-
erous tubule basement membrane by producing lami-
nin (15), immunoexpression of which was disrupted in
PTM-ARKO testes, with a less well defined “ring” of
laminin evident in the basement membrane compared
with that in WT testes (Fig. 7B). This disruption was
progressive and became more apparent at d50–100
(Fig. 7B).
Effect of PTM-ARKO on cell-cell communication
in the testes: SC function
SC number (WT: 3.5940.3739106, KO: 2.6680.3564
106; P0.1) and nuclear size (WT: 337.554.30 m3, KO:
351.126.10m3; P0.8) were not significantly altered in
the PTM-ARKO mice at d100. Expression of immature
markers such as cytokeratin and anti-Mu¨llerian hormone
was lost in SCs from PTM-ARKO mice (data not shown),
whereas maturation markers such as GATA1 and p27kip
were activated and maintained through to adulthood as
Figure 3. Gross morphology of the reproductive system from
PTM-ARKO mice. A) Urogenital tract from males at d100 in
which the testes (T; inset) and seminal vesicles (arrow) are
obviously smaller in the PTM-ARKO than in the WT mice.
B) Quantification of testis weight in PTM-ARKO mice from
d12 to 100. Testis weight is not reduced in Cre-positive,
ARflox-negative mice (Cre). Values are means  se; n  6–14
mice. K, kidney; B, bladder. ***P
 0.001 vs. WT. Scale bars
50 mm.
Figure 4. Elongate sperm were rarely seen in
the caput epididymis from PTM-ARKO adult
mice, unlike in WT adults (asterisk). Cell debris
was observed in the lumen of PTM-ARKO epi-
didymides. Scale bars  50 m.
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normal (data not shown). As observed in WT littermates,
AR was expressed in PTM-ARKO SCs at d12–100, (d12–
50, data not shown; d100, Fig. 1D). Expression of SC-
specific genes previously shown to be androgen depen-
dent (Rhox5, Eppin, and Tubb3) (28) and androgen
independent [androgen-binding protein (ABP) (29) and
Wilms’ tumor-1 (WT-1) (30)] were examined by quanti-
tative RT-PCR. This analysis demonstrated that relative
expression of Rhox5, Eppin, Tubb3, and WT-1 were all
significantly decreased in PTM-ARKO testes at d100,
whereas ABP was not significantly altered compared with
that in WT littermates (Fig. 8A). However, both WT-1 and
Tubb3 protein could be detected in SCs from PTM-ARKO
WT and KO mice at d100 by immunohistochemistry (Fig.
8B, C). Serum FSH concentrations were significantly
increased (WT: 18.111.386 ng/ml, KO: 25.910.6913
ng/ml; P  0.0005) at d100 in PTM-ARKO males com-
pared with WT males. SC orientation in PTM-ARKOs
became progressively disorganized with SC nuclei no
longer located at the base of the seminiferous tubules
at d100, as in WT testes, but instead often located in
the middle of tubules (Fig. 8C).
Effect of PTM-ARKO on LC function and hormone
profiles
PTM-ARKO males displayed normal AR expression in
LCs, identified by costaining for AR and 3HSD (Fig. 9A).
An apparent increase in the size and/or number of LCs
was noted in the PTM-ARKO testis at d100, compared
with that in WT littermates (Fig. 9A). However, quan-
tification revealed no change in LC size (P0.34) or
number (P0.35) in PTM-ARKO mice at d100, com-
pared with WT mice and the apparent increase in LCs
observed histologically was due to the reduced seminif-
erous tubule volume. Serum testosterone concentra-
tions were not significantly altered in PTM-ARKO mice
at any age examined compared with WT mice (Fig. 9B).
In contrast, serum LH and intratesticular testosterone
concentrations (expressed per 100 mg of testis and per
testis, respectively) were increased in adult PTM-ARKO
males (Fig. 9B). LH receptor expression immunoexpres-
sion was readily detectable in PTM-ARKO testes at d100,
as observed in WT mice (Fig. 9C).
Figure 6. GC volume in PTM-ARKO and WT testes. Total
GC nuclear volume per testis was significantly reduced in
PTM-ARKO testes from d21 onward, compared with that in
WT testes. Values are means  se; n  4 – 6 mice. ***P 

0.001 vs. WT.
Figure 5. Histological comparison of PTM-ARKO and WT
testes at d12–100. A) PTM-ARKO testes look comparable to
WT testes at d12, whereas at d21 seminiferous tubules appear
smaller in PTM-ARKO testes, with fewer GCs. Unlike in WT
testes, spermatogenesis was disrupted and incomplete in
PTM-ARKO testes at d50 and 100. Lumens (asterisks) were
smaller/absent in the seminiferous tubules in PTM-ARKO
testes at all ages, unlike in WT testes. PTM cells (arrow) were
seen surrounding seminiferous tubules at all ages in both WT
and PTM-ARKO testes. B) Percentage of the testis occupied
by seminiferous tubule lumen was significantly reduced from
d21 in PTM-ARKO testes compared with WT testes. Values are
means  se; n  4–6 mice. ***P 
 0.001 vs. WT littermates.
Scale bars  50 m.
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DISCUSSION
We have investigated the effect of two different smooth
muscle-driven Cre lines (SM22-Cre and smMHC-Cre)
on cell-specific ablation of testicular AR from mouse
testes. We show that cross-breeding ARflox female mice
with the SM22-Cre line does not alter AR expression in
testicular PTM cells, whereas the smMHC-Cre line does
delete AR from a proportion of PTM cells; both lines
deleted AR from smooth muscle cells surrounding
testicular blood vessels. This differential effectiveness of
these Cre lines is consistent with the demonstration
that Cre recombinase is poorly expressed in testes from
SM22-Cre mice (19) yet highly expressed in testes from
smMHC-Cre mice (19) and explains the very different
testicular phenotypes we observed when these mouse
lines were used to ablate AR. Namely, using the SM22-
Cre line (i.e., deleting AR from blood vessels) did not
affect fertility, as reported previously using the same
Cre line (18), whereas using the smMHC-Cre line
(resulting in PTM-ARKO mice) abolished sperm pro-
duction and fertility, despite the fact that not all PTM
cells are AR-negative. Note that any potential con-
founding effects resulting from additional ablation of
AR in the blood vessels in PTM-ARKO mice can be
accounted for by the phenotype induced by the blood
vessel-specific SM22-Cre line (18). Our results are
therefore the first in vivo demonstration that androgen
action on PTM cells is essential for normal spermato-
genesis and fertility.
In contrast with ARKO mice (8), reproductive tract
formation and testes descent were normal in PTM-
ARKO males. However, the testes were almost 70%
smaller in PTM-ARKO adult males than in their WT
littermates, with almost no sperm production. Interest-
ingly, at d12 there was no reduction in testis weight in
PTM-ARKO males, and the testes were histologically
comparable to WT testes with no reduction in GCs. Cre
recombinase was expressed in the PTM cells from
e17.5; this finding may imply that PTM-mediated AR
signaling is not essential before puberty. However, in
our PTM-ARKO mice, AR is not deleted from all PTM
cells. Therefore, the lack of an obvious phenotype at
d12 may reflect patchy AR deletion and the fact that the
remaining AR-positive PTM cells are sufficient to en-
able normal early testis development; this theory re-
quires further investigation. Despite the patchy AR
deletion from PTM cells, all PTM-ARKO males were
infertile, and spermatogenesis was severely impaired.
This finding demonstrates a crucial role for PTM-
dependent AR signaling in male fertility.
PTM-ARKO mice were azoospermic with a significant
reduction in all types of GCs. This reduction in GCs in
PTM-ARKO mice became progressively worse from d21
onward, with almost no elongate spermatids in adults.
Indeed, the reduction in both spermatocyte and sper-
matid number is greater than that reported in SCARKO
mice (8). Because of the structure of the seminiferous
epithelium and the presence of inter-SC tight junc-
tions, any effect on postmeiotic GCs must be mediated
via the SCs; this result therefore suggests that the
reduction in postmeiotic GCs in PTM-ARKO mice is
likely to be mediated via interactions with and effects
on SCs. As in ARKOs (8), spermatogonial numbers
were reduced in PTM-ARKO mice, unlike in SCARKO
mice in which spermatogonial numbers are normal and
there is a specific block in GC maturation at meiosis
(8). Our data suggest that spermatogonial number may
be regulated by androgens acting via PTM cells; this is
perhaps not surprising because PTM cells are in inti-
mate contact with these basally located GCs. In their
studies on SM22-AR	/y mice, Zhang et al. (18) reported
a 25% reduction in GC number, but no change in GC
ratio, therefore confirming that the 85% reduction in
GCs and spermatogonial loss in our PTM-ARKOs is due
to ablation of AR from PTM cells not from the smooth
muscle surrounding the blood vessels. This reduction
in spermatogonia in PTM-ARKO mice may be due to
alterations to the basement membrane and so reduced
attachment. The reduction in GCs in PTM-ARKO mice
is similar to that reported in rats with reduced testicular





d21 PTMARKO WT 0.5  0.1 1.8  0.2 NA 2.7  0.5
PTMARKO KO 0.4  0.4 (80%) 0.5  0.1 (28%)*** NA 1.0  0.2 (37%)***
d50 PTMARKO WT 0.8  0.1 6.4  0.5 8.9  1.1 15.9  1.1
PTMARKO KO 0.6  0.1 (75%) 3.1  0.6 (48%)* 0.9  0.3 (10%)*** 6.2  1.8 (39%)*
d100–140 PTMARKO
(d100)
WT 0.8  0.1 6.4  0.5 9.3  0.7 12  0.9
PTMARKO
(d100)
KO 0.3  0.04 (38%) 1.5  0.5 (23%)* 0.6  0.3 (6%)*** 3.1  0.8 (26%)***
SCARKO
(d140)
WT 1.2  0.3 11.8  1.4 16.4  1.9 18.1  2.1
SCARKO
(d140)
KO 0.7  0.1 (58%) 5.8  0.7 (49%)* 0.3  0.1 (2%)*** 4.9  0.7 (27%)**
Data are expressed as average nuclear volume, indicative of total GC volume per testis. Values are means  se for 4–8 mice. Values in
PTM-ARKOs as a percentage of the WT are indicated in parentheses. NA, not available. *P 
 0.05, **P 
 0.01, ***P 
 0.001 vs. WT.
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androgen concentrations (1, 31). This finding suggests
that the phenotype reported in these androgen-defi-
cient rats may be due in part to PTM cell-mediated
effects and not just to altered androgen-dependent SC
signaling, which has previously been the primary focus.
Although our results in PTM-ARKO mice demonstrate
an essential role for AR signaling via PTM cells in GC
maturation, it is also important to consider what effect
this has on other cell types, namely the SCs (via
stromal-epithelial interactions) and LCs.
It has long been recognized that stromal-epithelial
interactions play a vital role in mediating androgen
action throughout the male reproductive tract, but
there is little in vivo evidence for this role in the testis.
In mice, SC proliferation occurs during late fetal and
early neonatal life (32) and is believed to be mediated
in part by androgens, possibly acting via PTM cells
because the SC number is dramatically reduced in
ARKO mice but only slightly reduced in SCARKO mice
(27). However, in our studies, no reduction in SC
number was found in PTM-ARKO mice at d100, unlike
in ARKOs (33). This finding could suggest that SC
number is not determined by AR signaling via PTM
cells. However, as AR was not ablated from all PTM cells
in our PTM-ARKOs, residual PTM AR signaling may
have been sufficient to allow normal SC proliferation;
this theory merits further investigation. Based on sev-
eral key criteria, SCs mature normally in PTM-ARKO
testes and express AR, suggesting that these processes
are not dependent on AR signaling via PTM cells and
that any changes in SC function cannot be attributed to
any gross alteration in maturation or AR expression in
SCs themselves. However, in PTM-ARKO testes, each
SC supported fewer GCs than in WT littermates and
seminiferous tubule diameter and lumen volume were
both reduced, similar to the phenotype reported in
ARKO and SCARKO testes (8). The presence of a
lumen reflects production of seminiferous tubule fluid
by SCs, which has previously been shown to be depen-
dent on FSH (34, 35) during puberty and on androgens
later in life (6, 8). Thus, our results demonstrate that
SC function is altered in PTM-ARKO testes, even
though the SCs continue to express AR and FSH levels
are elevated. This important new finding highlights an
Figure 7. Evaluation of PTM cell protein expression in WT and PTM-ARKO males. A) Desmin (immunostained brown) is
expressed in PTM cells (black arrow) in WT testes at d12–100, but expression was reduced in the PTM-ARKO testes at all ages
(arrowhead). Desmin expression around the blood vessels was not altered (white arrow). B) Demarcation of the basement
membrane by immunostaining for laminin (brown). Note that laminin forms a defined ring at the basement membrane of
seminiferous tubules in WT testes (arrow) but is less defined around PTM-ARKO tubules (arrowhead). WT and KO testes were
stained together on the same slides. Scale bars  50 m.
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indirect role (via PTM cells) for AR signaling in medi-
ating SC function and may offer some explanation for
the reduced GC development and infertility seen in
PTM-ARKO mice. For example, reduced seminiferous
tubule fluid production will affect nutrient transport to
the GCs (6) and would impair spermatogenesis. This
new in vivo evidence for androgen-dependent stromal
(PTM)-epithelial (SC) interactions in the testis parallels
the androgen-driven mechanisms reported to mediate
development and function of the rest of the male
reproductive tract (9, 10).
Despite many years of study, exactly how androgens
regulate spermatogenesis is not known. Studies in
SCARKO mice have identified changes in SC gene
expression, which could affect spermatogenesis (27,
28). Reductions in expression of three of these andro-
gen-dependent SC-specific genes, Rhox5, Tubb3, and
Eppin, were identified in PTM-ARKO testes at d100,
providing further evidence for altered SC function.
Conversely, expression of ABP, another SC-specific
gene, was not significantly altered in PTM-ARKO testes,
unlike in SCARKO testes in which ABP was increased
(27). These results suggest that genes previously re-
ported to be dependent on androgen action in SCs (27,
28), may also be affected by androgens acting via PTM
cells and that a complex dynamic exists between PTM
and SCs that may affect their ability to respond to
hormones. This observation highlights possible mech-
anisms via which spermatogenesis could be affected in
PTM-ARKO mice. These changes in gene expression
Figure 8. Evaluation of SC function in WT and PTM-ARKO males. A) Relative expression of SC genes was examined by
quantitative RT-PCR in WT and PTM-ARKO testes at d100. B) Expression of Tubb3 protein (brown) in SCs in both PTM-ARKO
and WT littermates at d12 and 100. The apparent altered pattern of expression of Tubb3 in PTM-ARKO mice at d100 is probably
due to reduction in the GC complement. C) WT-1 staining (brown) was used to identify SC nuclei and highlighted their
disorganization in PTM-ARKO males (arrow), compared with WT males (arrowhead). Values are means  se; n  5 mice. Scale
bars  50 m.
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provide further in vivo evidence that altered AR signal-
ing via the stromal PTM cells has “knock-on” effects on
the function of the epithelial SCs and thereafter on GC
development. WT-1 gene expression was also reduced
in PTM-ARKO testes, yet WT-1 protein could still be
detected by immunohistochemistry. This result merits
further investigation into the implications on SC func-
tion; however, it has been shown that WT-1 heterozy-
gous KO mice are fertile (36), suggesting that this
reduction in WT-1 mRNA in PTM-ARKO mice may not
affect fertility.
PTM cells in mice are normally arranged in a single
layer surrounding the seminiferous tubules, but in
ARKO mice, PTM cells form multiple layers (8). PTM
cell layering was normal in both PTM-ARKO and
SCARKO testes (8), which could suggest that neither
PTM nor SC AR signaling regulates PTM cell layering.
However, because AR has not been ablated from all
PTM cells in our PTM-ARKO mice, the residual PTM
AR signaling could be sufficient to maintain PTM cells
in a normal single layer. It is believed that this single
layer of PTM cells contract to help with transport of
mature sperm through the seminiferous tubules (37).
In PTM-ARKO testes, a progressive decrease was noted
in the immunoexpression of desmin and SMA in PTM
cells but not in the smooth muscle cells surrounding
the blood vessels. This reduction in smooth muscle
protein expression in PTM cells may reflect an andro-
gen-dependent loss of a smooth muscle phenotype,
resulting in an impaired ability to contract. This possi-
ble androgen dependency of PTM cell contractility has
been reported previously in vitro (38) and merits fur-
ther study.
PTM cells are also involved in laying down the
basement membrane, which not only gives the seminif-
erous tubule structural support but is also thought to be
important for communication with and effects on SCs.
Disruption to the basement membrane surrounding
the seminiferous tubules in PTM-ARKOs is likely to
impair cell communication particularly with the neigh-
boring SCs and spermatogonia. This finding may have
implications for maintaining spermatogonia within
their niche attached to the basement membrane, which
permits their movement laterally along the basement
membrane (reviewed in ref. 39) and merits further
investigation in PTM-ARKO testes. The seminiferous
epithelium appeared disorganized in PTM-ARKO tes-
tes, with SC nuclei often displaced from their normal
basal location, suggesting that these SCs may also be
losing their attachment to the damaged basement
membrane, similar to that reported in SCARKO testes
(40). This disorganization and apparent lack of polarity
observed in PTM-ARKO testes is likely to have implica-
tions for SC function and is probably due to altered
Figure 9. Evaluation of LC function in WT and PTM-ARKO males. A) LCs (arrow, immunostained green for 3HSD)
immunostained positively for AR (red) in PTM-ARKO and WT males. B) Serum testosterone concentrations were not
significantly different in PTM-ARKO males, compared with WT males, whereas serum LH and intratesticular testosterone
concentrations were both significantly increased in PTM-ARKO males at d100. C) LCs (arrow) in the PTM-ARKO express the
LH receptor (LHR; immunostained green, counterstained red) at d100, similar to WT control males. Values are means  se;
n  8–18 mice. **P 
 0.01 vs. WT littermates. Scale bars  50 m.
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signaling from the PTM cells as well as the reduction in
spermatogonial number, as it has been shown that the
presence of GCs plays a role in maintaining SC size and
organization within seminiferous tubules (41, 42).
These data highlight an important role for androgen
signaling via PTM cells in maintaining normal seminif-
erous tubule structure and function and may offer a
possible mechanism for impaired GC development and
infertility in PTM-ARKOs.
LC AR expression was normal in PTM-ARKO testes,
implying that any effect on LC function must be due to
deletion of AR from PTM cells and/or the smooth
muscle cells around the blood vessels. LC number per
testis was also unchanged in PTM-ARKO testes at d100,
compared with WT testes. This result is in contrast to
the decrease in LC number seen in ARKO, SCARKO,
and FSHRKO testes in adulthood (43, 44) and is in
agreement with the belief that SCs and not the PTM
cells regulate LC number via both FSHR and AR
signaling (43, 44). It is less clear what regulates adult
LC size, with a reduction reported in ARKO testes (43),
an increase in SCARKO testes (43), and no change in
PTM-ARKO testes. The primary function of the LC is to
produce testosterone and in PTM-ARKO adult males
serum testosterone concentrations were unaltered
whereas intratesticular testosterone (ITT) and serum LH
were both elevated. This elevation was not due to any
obvious deficiencies in LHR expression in LCs but is
indicative of compensatory LC failure, which may be
the result of impaired transport of the testicular testos-
terone out into the bloodstream and so reduced nega-
tive feedback to the pituitary. The hormone profile
reported here in PTM-ARKO mice is similar to that
reported in ARKO mice, whereas no increase in serum
LH or testosterone levels was observed in SCARKO
adult mice (43). Furthermore, no change in serum
testosterone or LH was reported by Zhang et al. (18)
with SM22-Cre to ablate AR expression. Taken to-
gether, these results suggest that the changes in hor-
mone concentrations reported here in PTM-ARKO
mice are specifically due to ablating AR from the PTM
cells and not to deletion of AR from the blood vessel
smooth muscle cells. High ITT is associated with sper-
matogonial arrest (45); therefore, the high ITT in
PTM-ARKO mice might also offer some explanation for
the reduced GC numbers.
CONCLUSIONS
We have successfully generated a PTM-ARKO mouse
model that demonstrates the essential role in vivo for
AR signaling via the PTM cells in normal spermatogen-
esis and male fertility. This is mediated in part via
altered SC function, thus providing new in vivo evi-
dence for androgen-driven stromal-epithelial interac-
tions in the testis and their vital role in normal male
fertility. This mouse model provides a unique tool to
identify the underlying molecular mechanisms of an-
drogen action via the PTM cells in spermatogenesis,
which could provide insight for the development of
new male contraceptives and treatments for male
infertility.
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